NBMolecules™,a privately held Swiss company offering SurfLink™, a revolutionary permanent bio-mimicking surface treatment for bone anchored implants. The SurfLink treatment is compatible with any surface roughness or porosity. Through its bone-like characteristics, SurfLink promotes true osseointegration. Studies have shown bone growing directly on the implant surface, enhancing both early integration and long-term stability. The SurfLink technology was developed over a period of 12 years by a multidisciplinary team from a number of renowned academic institutions including the University of Geneva (‘UniGe’), Ecole Polytechnique Fédérale de Lausanne (‘EPFL’), the University of Zürich and the University of Bern. This collaboration has given rise to a highly sophisticated surface treatment technology which offers a range of benefits not found in any other single surface treatment. NBMolecules SurfLink technology is protected by patents owned by the UniGe and EPFL. According to a license agreement entered into with UniGe and EPFL, the university spin-off company NBMolecules, established in 2002, owns the worldwide exclusive right to full and unrestricted use, development and exploitation of the technology. In 2008 NBMolecules established new laboratories and an office in Canton de Vaud, Switzerland. Over 65 contracts with research institutions and other external service providers have been established, and the company continues to grow.
Gland
2002
1–10
